CJC-1295 (no DAC)

CJC-1295 (no DAC)

Modified GRF 1-29

GHRH analog — amplifies the natural GH pulse

Muscle GrowthAnti-AgingFat Loss ★ 90
Half-life
30 min - 2 hours (no DAC), 6-8 days (with DAC)
Cycle
12-16 weeks on, 4 weeks off
Storage
Lyophilized: freezer. Reconstituted: 2-8°C, 28 days.
Research
Phase II trials, widespread off-label use

About

A synthetic GHRH (Growth Hormone Releasing Hormone) analog that activates pituitary GHRH receptors. Without DAC, the short half-life preserves natural pulsatility.

Mechanism

Binds GHRH receptors in pituitary somatotrophs, stimulating GH production and release.

Dosage

100 mcg
1x per day before sleep
0102030405060708090100

Draw to 4 units on a U-100 insulin syringe

5 mg · 2 mL BAC

Route
SubQ
Duration
8-12 weeks

When to take: Best on an empty stomach, 30-60 min before food or sleep. Almost always paired with Ipamorelin.

Reconstitution

Vial size (mg): 5 mg · BAC water (mL): 2 mL · Concentration: 2500 mcg/mL

Can be combined with Ipamorelin in the same syringe (same concentration).

Benefits

  • Raises GH and IGF-1
  • Muscle building
  • Fat loss (especially visceral)
  • Improved sleep
  • Slower aging
  • Improved energy and recovery

Side effects

  • Facial flushing — transient
  • Tingling
  • Headache
  • Fluid retention (rare)

Gender notes

Common stack: 200 mcg + 200 mcg Ipamorelin nightly.

Cautions

  • Active cancer
  • Pregnancy
  • Pituitary disease
  • Insulin resistance (caution)

Research

Stacks well with

IpamorelinBPC-157Tesamorelin
Add reminder Calculator